2 research outputs found
A case report: The first show phenomenon in the treatment of spinal cord injury with Regentime procedure using autologous bone marrowâderived stem cells
Key Clinical Message Promising outcomes are shown in this case report using the Regentime procedure and autologous stem cells to treat spinal cord injury. The observed âFirst Show Phenomenonâ provides valuable insights into the therapy's potential for spinal cord injury. Abstract This case report demonstrates âthe first show phenomenonâ following Regentime stem cell therapy applied to a spinal cord injury patient. A 40âyearâold gentleman sustained a ballistic injury at the level of T9, resulting in complete bilateral motor and sensory loss from T9 and below. He was treated with autologous bone marrowâderived mononuclear stem cells injected into his spinal canal 2.5âyears after his injury. Followâup during the firstâweek posttransplantation showed early symptom improvement termed âthe first show phenomenon.â He regained sensation to light touch in his lower limbs by the end of week 1 and reported no serious implications or complications
The Regentime stem cell procedure, successful treatment for a CharcotâMarieâTooth disease case
Key Clinical Message This report highlights the successful treatment of a CharcotâMarieâTooth disease case using the Regentime stem cell procedure, suggesting its potential as a promising therapeutic approach for patients suffering from this challenging condition